Smallpox

Phase I Trial of an Investigational Small Pox Medication

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

MVA Post-Event: Administration Timing and Boost Study

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel

Safety Surveillance Study of ACAM2000® Vaccinia Vaccine

Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults

Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years